About the Journal

Annals of Lymphoma

The Annals of Lymphoma (Ann Lymphoma; ISSN 2616-2695) is an open-access, international peer-reviewed electronic journal, and openly distributed worldwide. It publishes articles that describe advances in basic and translational science, and clinical findings relating to human lymphoma. Specific areas of interest include, but are not limited to: epidemiology, biology, genetics, immunology, diagnosis, treatment, and measures of assessment of response. The aim of the journal is to provide a forum for the dissemination of original research articles, as well as reviews and perspectives in these areas as they relate to human lymphoma. The journal features an international Editorial Board comprised of distinguished specialists who have dedicated their careers to the study of lymphoma in the laboratory and the clinic. They will bring their broad spectrum of experience to assist the journal in achieving its goals. AOL is endorsed by Lymphoma Research Foundation.

Submission Turnaround Time:
• Submission to First Editorial Decision: 2-4 weeks.
• External peer review: 1-2 months.
• Acceptance to Publication: 2-4 weeks. Original Articles are listed as priority.

AME Publishing Company
Address: Rm C, 16/F, Kings Wing Plaza 1, No. 3 On Kwan Street, Shatin, NT, Hong Kong
Phone: +86 20 66355775
Email: aol@amegroups.com

Updated on April 15, 2019